1-12 of 12
Xu Zhang
Close
Sort by
Journal Articles

Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant

Clinical Trials & Observations
Scott R. Solomon, Melhem Solh, Lawrence E. Morris, Jr., H. Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Caitlin Guzowski, Katelin C Jackson, Stacey Brown, Asad Bashey
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5215–5224.
https://doi.org/10.1182/bloodadvances.2023010477
Published: 2023
Includes: Supplemental data
Journal Articles

Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF

Vinzon Ibanez, Kestis Vaitkus, Xu Zhang, Jagadeesh Ramasamy, Angela E. Rivers, Yogen Saunthararajah, Robert Molokie, Donald Lavelle
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3891–3902.
https://doi.org/10.1182/bloodadvances.2022009558
Published: 2023
Journal Articles

Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors

Asad Bashey, Xu Zhang, Lawrence E. Morris, H. K. Holland, Lizamarie Bachier-Rodriguez, Scott R. Solomon, Melhem Solh
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3816–3823.
https://doi.org/10.1182/bloodadvances.2023009765
Published: 2023
Includes: Supplemental data
Journal Articles

Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice

Guohui Ren, Suman Setty, Xu Zhang, Alexandru Susma, Maria Armila Ruiz, Richard D. Minshall, James P. Lash, Victor R. Gordeuk, Santosh L. Saraf
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4403–4407.
https://doi.org/10.1182/bloodadvances.2022007809
Published: 2022
Includes: Supplemental data
Journal Articles

Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide

Clinical Trials & Observations
Scott R. Solomon, Michael T. Aubrey, Xu Zhang, Katelin C. Jackson, Lawrence E. Morris, H. Kent Holland, Melhem M. Solh, Asad Bashey
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5311–5321.
https://doi.org/10.1182/bloodadvances.2020003110
Published: 2020
Includes: Supplemental data
Journal Articles

The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Melhem M. Solh, Dawn Speckhart, Scott R. Solomon, Asad Bashey, Lawrence E. Morris, Xu Zhang, H. Kent Holland
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4812–4821.
https://doi.org/10.1182/bloodadvances.2020002204
Published: 2020
Journal Articles

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

Clinical Trials & Observations
Scott R. Solomon, Melhem Solh, Xu Zhang, Stacey Brown, Katelin C. Jackson, H. Kent Holland, Lawrence E. Morris, Asad Bashey
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3669–3676.
https://doi.org/10.1182/bloodadvances.2020001958
Published: 2020
Includes: Supplemental data
Journal Articles

Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia

Xu Zhang, Kiarri N. Kershaw, Caterina P. Minniti, Andrew Campbell, Sohail R. Rana, Deepika S. Darbari, Lori Luchtman-Jones, Craig Sable, Niti Dham, Gregory Ensing, Manuel Arteta, James G. Taylor, VI, Lewis L. Hsu, Sergei Nekhai, Victor R. Gordeuk
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3311–3314.
https://doi.org/10.1182/bloodadvances.2020002077
Published: 2020
Journal Articles

Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease

Andrew Srisuwananukorn, Rasha Raslan, Xu Zhang, Binal N. Shah, Jin Han, Michel Gowhari, Robert E. Molokie, Victor R. Gordeuk, Santosh L. Saraf
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1978–1986.
https://doi.org/10.1182/bloodadvances.2019001384
Published: 2020
Includes: Supplemental data
Journal Articles

HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis

Mohamad A. Meybodi, Wenhao Cao, Leo Luznik, Asad Bashey, Xu Zhang, Rizwan Romee, Wael Saber, Mehdi Hamadani, Daniel J. Weisdorf, Haitao Chu, Armin Rashidi
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2581–2585.
https://doi.org/10.1182/bloodadvances.2019000614
Published: 2019
Includes: Supplemental data
Journal Articles

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial

Clinical Trials & Observations
Jessica C. Cardenas, Xu Zhang, Erin E. Fox, Bryan A. Cotton, John R. Hess, Martin A. Schreiber, Charles E. Wade, John B. Holcomb
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1696–1704.
https://doi.org/10.1182/bloodadvances.2018017699
Published: 2018
Includes: Supplemental data
Journal Articles

Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts

Clinical Trials & Observations Global Advances
Santosh L. Saraf, Titilola S. Akingbola, Binal N. Shah, Chinedu A. Ezekekwu, Omowunmi Sonubi, Xu Zhang, Lewis L. Hsu, Mark T. Gladwin, Roberto F. Machado, Richard S. Cooper, Victor R. Gordeuk, Bamidele O. Tayo
Journal: Blood Advances
Blood Adv (2017) 1 (11): 693–698.
https://doi.org/10.1182/bloodadvances.2017005231
Published: 2017